Publications: MR Lachlan Gilchrist
(
2026
)
.
Splitting schizophrenia: divergent cognitive and educational outcomes revealed by genomic structural equation modelling
.
Molecular Psychiatry1
-
10
.
(
2026
)
.
Circulating inflammatory proteins predict dementia risk, and are linked to structural brain changes and modifiable risk factors
.
Alzheimer's Research & Therapy
vol.
18
,
(
1
)
Howard DM, Gilchrist L, Proitsi P, Paul ER, Heilig M, Östman L, Kämpe R, Hamilton JP
(
2025
)
.
Immune and metabolic disturbance as a function of genetic risk and phase of illness in major depression
.
Brain Behavior & Immunity - Health
vol.
50
,
Jareebi MA, Fullerton J, Kancheva AK, Tank R, Gilchrist L, Russell ER, Lyall LM, Ward J et al.
(
2025
)
.
Associations and interactions between premorbid cognitive health, apolipoprotein e4 genotype, and incident Alzheimer’s disease in UK Biobank (N = 252,340)
.
npj Dementia
vol.
1
,
(
1
)
Gilchrist L, Mutz J, Hysi P, Legido-Quigley C, Kõks S, Lewis CM, Proitsi P
(
2025
)
.
Evaluating metabolome-wide causal effects on risk for psychiatric and neurodegenerative disorders
.
BMC Medicine
vol.
23
,
(
1
)
Gilchrist L, Spargo TP, Green RE, Coleman JRI, Howard DM, Thorp JG, Adey BN, Lord J et al.
(
2025
)
.
Depression symptom-specific genetic associations in clinically diagnosed and proxy case Alzheimer’s disease
.
Nature Mental Health
vol.
3
,
(
2
)
212
-
228
.
Spargo TP, Gilchrist L, Hunt GP, Dobson RJ, Al-Chalabi A, Pain O
(
2024
)
.
Statistical examination of shared loci in neuropsychiatric diseases using genome-wide association study summary statistics
.
eLife
vol.
12
,
Green RE, Lord J, Scelsi MA, Xu J, Wong A, Naomi-James S, Handy A, Gilchrist L et al.
(
2023
)
.
Investigating associations between blood metabolites, later life brain imaging measures, and genetic risk for Alzheimer’s disease
.
Alzheimer's Research & Therapy
vol.
15
,
(
1
)
Mutz J, Gilchrist L, Pain O, Proitsi P, Lewis CM
.
Accelerated metabolomic ageing (MileAge) in mid-life predicts incident vascular, unspecified and all-cause dementia
.
Liu Y, Abdolkarimi D, Gilchrist L, Calhas S, Wretlind A, Velayudhan L, Ashton NJ, Zetterberg H et al.
.
Circulating Metabolites are Linked to Dementia and Brain Imaging Phenotypes, and Mediate Modifiable Risk Pathways
.
Abdolkarimi D, Liu Y, Gilchrist L, Calhas S, Waters S, Marshall CR, Proitsi P
.
Circulating inflammatory proteins predict dementia risk, are linked to structural brain changes and reveal risk mediation pathways
.
Gilchrist L, Mutz J, Hysi P, Legido-Quigley C, Koks S, Lewis CM, Proitsi P
.
Evaluating metabolome-wide causal effects on risk for psychiatric and neurodegenerative disorders
.
Gilchrist L, Pain O, Marriott H, Pfaff A, Watson CJ, Iacoangeli A, Koks S, Lewis CM et al.
.
Using polygenic and transcriptional risk scores to investigate psychiatric and cognitive symptoms in Parkinson’s disease
.